Page last updated: 2024-10-27

fexofenadine and Urolithiasis

fexofenadine has been researched along with Urolithiasis in 1 studies

fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.

Urolithiasis: Formation of stones in any part of the URINARY TRACT, usually in the KIDNEY; URINARY BLADDER; or the URETER.

Research Excerpts

ExcerptRelevanceReference
"Urolithiasis is expected to cause a considerable complication in patients with systemic mastocytosis."1.35Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics. ( Homann, J; Kolck, UW; Molderings, GJ; Schröder, D; Solleder, G; von Kügelgen, I; Vorreuther, R, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Molderings, GJ1
Solleder, G1
Kolck, UW1
Homann, J1
Schröder, D1
von Kügelgen, I1
Vorreuther, R1

Other Studies

1 other study available for fexofenadine and Urolithiasis

ArticleYear
Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics.
    Urological research, 2009, Volume: 37, Issue:4

    Topics: Diagnosis, Differential; Glucocorticoids; Histamine H1 Antagonists, Non-Sedating; Histamine H2 Antag

2009